(via Low Molecular Weight Heparins (LMWH) - Dalteparin, Enoxaparin, Fondaparinux & Tinzaparin)


#iwtv#interview with the vampire#assad zaman#the vampire armand



seen from Russia
seen from China
seen from Brazil
seen from China
seen from United States

seen from Russia

seen from Malaysia
seen from Malaysia
seen from Spain
seen from Russia

seen from Malaysia

seen from United States

seen from China
seen from Armenia
seen from Poland
seen from Armenia

seen from T1

seen from Singapore

seen from United States

seen from United Kingdom
(via Low Molecular Weight Heparins (LMWH) - Dalteparin, Enoxaparin, Fondaparinux & Tinzaparin)
Tinzaparin Better for Cancer-Related VTE
Deep vein thrombosis (DVT) treatment with low-molecular-weight heparin tinzaparin cut the risk of recurrence in cancer patients, while also reducing clinically relevant nonmajor bleeding compared with warfarin, researchers said here.
Results from the phase III randomized CATCH trial demonstrated a near 35% reduction in recurrent venous thromboembolism (VTE) in symptomatic patients treated with tinzaparin (Innohep) compared with warfarin, Agnes Lee, MD, of the University of British Columbia in Vancouver, and colleagues found
Article